The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis
Open accessAbstract
There is a need to determine biomarkers reflecting disease activity and prognosis in primary sclerosing cholangitis (PSC). We evaluated the prognostic utility of the enhanced liver fibrosis (ELF) score in Norwegian PSC patients. Serum samples were available from 305 well‐characterized large‐duct PSC patients, 96 ulcerative colitis patients, and 100 healthy controls. The PSC patients constituted a derivation panel (recruited 1992‐2006 [n = 167]; median age 41 years, 74% male) and a validation panel (recruited 2008‐2012 [n = 138]; median age 40 years, 78% male). We used commercial kits to analyze serum levels of hyaluronic acid, tissue inhibitor of metalloproteinases‐1, and propeptide of type III procollagen and calculated ELF scores by the previously published algorithm. Results were also validated by analysis of ELF tests using the ADVIA Centaur XP system and its commercially available reagents. We found that PSC patients stratified by ELF score tertiles exhibited significantly different transplant‐free survival in both panels ( P < 0.001), with higher scores associated with shorter survival, which was confirmed in the validation panel stratified by ELF test tertiles ( P = 0.003). The ELF test distinguished between mild and severe disease defined by clinical outcome (transplantation or death) with an area under the curve of 0.81 (95% confidence interval [CI] 0.73‐0.87) and optimal cutoff of 10.6 (sensitivity 70.2%, specificity 79.1%). In multivariate Cox regression analysis in both panels, ELF score (hazard ratio = 1.9, 95% CI 1.4‐2.5, and 1.5, 95% CI 1.1‐2.1, respectively) was associated with transplant‐free survival independently of the Mayo risk score (hazard ratio = 1.3, 95% CI 1.1‐1.6, and 1.6, 95% CI 1.2‐2.1, respectively). The ELF test correlated with ultrasound elastography in separate assessments. Conclusion : The ELF score is a potent prognostic marker in PSC, independent of the Mayo risk score. (H epatology 2015;62:188‐197)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ELF test can predict transplant-free survival in PSC 81,82 and retains predictive value longitudinally despite dynamic fluctuations in the course of PSC with regard to progression to cirrhosis (but without association between reduced values and improved outcome).79”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885 · cited 5×
“Albumin, g/L, median (range)* 40 (22-50) 34 (15-46) <0.”
InfluentialExtensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D’Agostino, R. B., & Steyerberg, E. W. (2010) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,483
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
Bédossa, P., Dargère, D., & Paradis, V. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.022 · Cited by 2,370
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R. W., Fevery, J., Kalloo, A. N., Nagorney, D. M., Boberg, K. M., Shneider, B. L., & Gores, G. J. (2009) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,230
Self-citationSerum markers detect the presence of liver fibrosis: A cohort study
Rosenberg, W. M., Voelker, M., Thiel, R. P., Becka, M., Burt, A. D., Schuppan, D., Hübscher, S. G., Roskams, T., Pinzani, M., & Arthur, M. J. P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.052 · Cited by 1,103
Self-citationNatural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg–Gertzén, H., Wallerstedt, S. M., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 816
Guha, I. N., Parkes, J., Roderick, P. J., Chattopadhyay, D., Cross, R., Harris, S., Kaye, P., Burt, A. D., Ryder, S. D., Aithal, G. P., et al. (2007) · Hepatology · doi:10.1002/hep.21984 · Cited by 744
Self-citationSolberg, I. C., Lygren, I., Jahnsen, J., Aadland, E., Høie, O., Cvancarova, M., Bernklev, T., Henriksen, M., Sauar, J., Vatn, M. H., et al. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802600961 · Cited by 729
Self-citation
Cited by
Sorted by citations
Berzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., Petta, S., & Thiele, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.025 · Cited by 1,925
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
Self-citationGómez, E. V., & Chalasani, N. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.013 · Cited by 608
Weismüller, T. J., Trivedi, P. J., Bergquist, A., Imam, M., Lenzen, H., Ponsioen, C. Y., Holm, K., Gotthardt, D., Färkkilä, M. A., Marschall, H.-U., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.038 · Cited by 533
Self-citationPrimary sclerosing cholangitis
Dyson, J. K., Beuers, U. H., Jones, D. E. J., Lohse, A. W., & Hudson, M. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30300-3 · Cited by 496
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Bowlus, C. L., Arrivé, L., Bergquist, A. M., Deneau, M. R., Forman, L., Ilyas, S. I., Lunsford, K. E., Martínez, M., Sapisochín, G., Shroff, R. T., et al. (2022) · Hepatology · doi:10.1002/hep.32771 · Cited by 462
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Self-citationnorUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
Fickert, P., Hirschfield, G. M., Denk, G., Marschall, H.-U., Altorjay, I., Färkkilä, M., Schramm, C., Spengler, U., Chapman, R., Bergquist, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.009 · Cited by 297
Self-citationChapman, M. H., Thorburn, D., Hirschfield, G. M., Webster, G. G. J., Rushbrook, S. M., Alexander, G., Collier, J., Dyson, J. K., Jones, D. E., Patanwala, I., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317993 · Cited by 284
Self-citationTrauner, M. A., Gulamhusein, A. F., Hameed, B., Caldwell, S. H., Shiffman, M. L., Landis, C. S., Eksteen, B., Agarwal, K., Muir, A. J., Rushbrook, S., et al. (2019) · Hepatology · doi:10.1002/hep.30509 · Cited by 263
Deneau, M. R., El‐Matary, W., Valentino, P. L., Abdou, R., Alqoaer, K., Amin, M., Amir, A. Z., Auth, M., Bazerbachi, F., Broderick, A., et al. (2017) · Hepatology · doi:10.1002/hep.29204 · Cited by 230
Hirschfield, G. M., Chazouillères, O., Drenth, J. P., Thorburn, D., Harrison, S. A., Landis, C. S., Mayo, M. J., Muir, A. J., Trotter, J. F., Leeming, D. J., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.035 · Cited by 187
Self-citationPonsioen, C. Y., Chapman, R. W., Chazouillères, O., Hirschfield, G. M., Karlsen, T. H., Lohse, A. W., Pinzani, M., Schrumpf, E., Trauner, M., & Gores, G. J. (2015) · Hepatology · doi:10.1002/hep.28256 · Cited by 181
Self-citationEaton, J. E., Vesterhus, M. N., McCauley, B. M., Atkinson, E. J., Schlicht, E. M., Juran, B. D., Gossard, A. A., LaRusso, N. F., Gores, G. J., Karlsen, T. H., et al. (2018) · Hepatology · doi:10.1002/hep.30085 · Cited by 158
Self-citationAltered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis
Kummen, M., Thingholm, L. B., Rühlemann, M. C., Holm, K., Hansen, S. H., Moitinho-Silva, L., Liwinski, T., Zenouzi, R., Storm-Larsen, C., Midttun, Ø., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.058 · Cited by 129
Self-citationGoode, E. C., Clark, A., Mells, G. F., Srivastava, B., Spiess, K., Gelson, W., Trivedi, P. J., Lynch, K. D., Castren, E., Vesterhus, M. N., et al. (2018) · Hepatology · doi:10.1002/hep.30479 · Cited by 106
Self-citationde Vries, E. M. G., de Krijger, M., Färkkilä, M. A., Arola, J. T., Schirmacher, P., Gotthardt, D. N., Goeppert, B. F., Trivedi, P. J., Hirschfield, G. M., Ytting, H., et al. (2016) · Hepatology · doi:10.1002/hep.28963 · Cited by 105
Self-citationMousa, O. Y. S., Juran, B. D., McCauley, B. M., Vesterhus, M. N., Folseraas, T., Turgeon, C. T., Ali, A. H., Schlicht, E. M., Atkinson, E. J., Hu, C., et al. (2020) · Hepatology · doi:10.1002/hep.31652 · Cited by 109
Self-citationPonsioen, C. Y., Assis, D. N., Boberg, K. M., Bowlus, C. L., Deneau, M., Thorburn, D., Aabakken, L., Färkkilä, M., Petersen, B., Rupp, C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.046 · Cited by 95
Self-citationHyaluronan in immune dysregulation and autoimmune diseases
Nagy, N., Kuipers, H. F., Marshall, P. L., Wang, E., Kaber, G., & Bollyky, P. L. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.022 · Cited by 94
de Vries, E. M. G., Färkkilä, M., Milkiewicz, P., Hov, J. R., Eksteen, B., Thorburn, D., Chazouillères, O., Pares, A., Nygård, S., Gilja, O. H., et al. (2017) · Liver International · doi:10.1111/liv.13402 · Cited by 83
Self-citationTrivedi, P. J., Tickle, J., Vesterhus, M. N., Eddowes, P. J., Bruns, T., Vainio, J., Parker, R., Smith, D., Liaskou, E., Thorbjørnsen, L. W., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312354 · Cited by 83
Self-citationS2k Leitlinie Autoimmune Lebererkrankungen
Authors, Collaborators:, durch:, E. B., Deutsche Gesellschaft für Gastroenterologie, V. U. S. (. (., (DGIM), D. G. F. I. M., (DCCV), D. M. C. U. V., e.V., D. L., (DEGUM), D. G. F. U. I. D. M., (DGE-BV), D. G. F. E. U. B. V., (DGKJ), D. G. F. K. U. J., et al. (2017) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0043-120199 · Cited by 87
Vesterhus, M. N., & Karlsen, T. H. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01681-z · Cited by 85
Self-citationNordenvall, C., Olén, O., Nilsson, P. J., von Seth, E., Ekbom, A., Bottai, M., Myrelid, P., & Bergquist, A. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14393 · Cited by 78
Vesterhus, M. N., Holm, A., Hov, J. R., Nygård, S., Schrumpf, E., Melum, E., Thorbjørnsen, L. W., Paulsen, V., Lundin, K. E. A., Dale, I., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.019 · Cited by 75
Self-citationDesign and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis
Ponsioen, C. Y., Lindor, K. D., Mehta, R., & Dimick‐Santos, L. (2018) · Hepatology · doi:10.1002/hep.29882 · Cited by 78
Self-citationDay, J. W., Patel, P. J., Parkes, J., & Rosenberg, W. M. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.027359 · Cited by 77
Self-citationTrivedi, P. J., Corpechot, C., Pares, A., & Hirschfield, G. M. (2016) · Hepatology · doi:10.1002/hep.28128 · Cited by 71
Self-citationGallbladder and bile duct disease in Cystic Fibrosis
Assis, D. N., & Debray, D. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.07.006 · Cited by 71
Ehlken, H., Wroblewski, R., Corpechot, C., Arrivé, L., Rieger, T., Hartl, J., Lezius, S., Huebener, P., Schulze, K., Zenouzi, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164224 · Cited by 68
Giuffrida, P., Pinzani, M., Corazza, G. R., & Sabatino, A. D. (2016) · United European Gastroenterology Journal · doi:10.1177/2050640616640160 · Cited by 64
Self-citationPrimary sclerosing cholangitis
Rabiee, A., & Silveira, M. G. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-20-266 · Cited by 70
Kim, M. N., Han, J. W., An, J., Kim, B. K., Jin, Y., Kim, S., Lee, M., Lee, H. A., Cho, Y., Kim, H. Y., et al. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0506 · Cited by 65
Primary sclerosing cholangitis
Manns, M. P., Bergquist, A. M., Karlsen, T. H., Levy, C., Muir, A. J., Ponsioen, C. Y., Trauner, M., Wong, G. L., & Younossi, Z. M. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00600-x · Cited by 77
Self-citationAn, P., Wei, G., Huang, P., Li, W., Qi, X., Lin, Y., Vaid, K. A., Wang, J., Zhang, S., Li, Y., et al. (2020) · Liver International · doi:10.1111/liv.14490 · Cited by 57
Asrani, S. K. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.030 · Cited by 56
Trivedi, P. J., Muir, A. J., Levy, C., Bowlus, C. L., Manns, M. P., Lu, X., Crans, G., Chung, C., Subramanian, G. M., Myers, R. P., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.07.032 · Cited by 55
Recent Advances in the Management of Primary Sclerosing Cholangitis
Assis, D. N., & Bowlus, C. L. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.04.004 · Cited by 59
Tabibian, J. H., Ali, A. H., & Lindor, K. D. (2018) · Europe PMC (PubMed Central) · Cited by 55
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study
Eksteen, B., Bowlus, C. L., Montaño‐Loza, A. J., Lefebvre, E. A., Fischer, L., Vig, P., Martins, E. B., Ahmad, J., Yimam, K. K., Pockros, P. J., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1619 · Cited by 51
New Therapeutic Strategies for Primary Sclerosing Cholangitis
Williamson, K. D., & Chapman, R. W. (2016) · Seminars in Liver Disease · doi:10.1055/s-0035-1571274 · Cited by 47
Goet, J. C., Floreani, A., Verhelst, X., Cazzagon, N., Perini, L., Lammers, W. J., de Vries, A. C., van der Meer, A. J., van Buuren, H. R., & Hansen, B. E. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.012 · Cited by 48
Trauner, M. A., Bowlus, C. L., Gulamhusein, A. F., Hameed, B., Caldwell, S. H., Shiffman, M. L., Landis, C. S., Muir, A. J., Billin, A. N., Xu, J., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.07.024 · Cited by 45
Treatment of primary sclerosing cholangitis in children
Laborda, T. J., Jensen, M. K., Kavan, M., & Deneau, M. R. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i1.19 · Cited by 43
Fossdal, G., Mjelle, A. B., Wiencke, K., Bjørk, I., Gilja, O. H., Folseraas, T., Karlsen, T. H., Rosenberg, W. M., Giil, L. M., & Vesterhus, M. N. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100328 · Cited by 39
Self-citationPrimary Sclerosing Cholangitis: A Concise Review of Diagnosis and Management
Fricker, Z. P., & Lichtenstein, D. R. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05484-y · Cited by 40
Nielsen, M. J., Thorburn, D., Leeming, D. J., Hov, J. R., Nygård, S., Moum, B. A., Saffioti, F., Gilja, O. H., Boberg, K. M., Mazza, G., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14806 · Cited by 38
Self-citationEnhanced liver Fibrosis® test predicts liver-related outcomes in the general population
Saarinen, K., Färkkilä, M. A., Jula, A., Erlund, I., Vihervaara, T., Lundqvist, A., & Åberg, F. O. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100765 · Cited by 37
Self-citationSimbrunner, B., Marculescu, R., Scheiner, B., Schwabl, P., Bucsics, T., Stadlmann, A., Bauer, D. J. M., Paternostro, R., Eigenbauer, E., Pinter, M., et al. (2020) · Liver International · doi:10.1111/liv.14498 · Cited by 37
Jhaveri, K. S., Hosseini‐Nik, H., Sadoughi, N., Janssen, H. L. A., Feld, J. J., Fischer, S. E., Menezes, R. J., & Cheung, A. (2018) · European Radiology · doi:10.1007/s00330-018-5619-4 · Cited by 32
Bossen, L., Gerussi, A., Lygoura, V., Mells, G. F., Carbone, M., & Invernizzi, P. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.02.013 · Cited by 35
Selvaraj, E. A., Ba‐Ssalamah, A., Poetter‐Lang, S., Ridgway, G. R., Brady, J. M., Collier, J. D., Culver, E. L., Bailey, A. A., & Pavlides, M. (2021) · Hepatology Communications · doi:10.1002/hep4.1860 · Cited by 30
Systematic review: non‐invasive prognostic tests for primary sclerosing cholangitis
Mazhar, A., & Russo, M. W. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16296 · Cited by 28
Trauner, M. A., Chung, C., Sterling, K., Liu, X., Lu, X., Xu, J., Tempany, C. M., Goodman, Z. D., Färkkilä, M. A., Tanaka, A., et al. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02653-2 · Cited by 27
Self-citationModulation of hyaluronan signaling as a therapeutic target in human disease
Garantziotis, S. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107993 · Cited by 26
Braadland, P. R., Schneider, K. M., Bergquist, A. M., Molinaro, A., Lövgren‐Sandblom, A., Henricsson, M., Karlsen, T. H., Vesterhus, M. N., Trautwein, C., Hov, J. R., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100561 · Cited by 26
Self-citationAdvances in the diagnosis and treatment of liver fibrosis
Cheng, J. Y., & Wong, G. L. (2017) · Hepatoma Research · doi:10.20517/2394-5079.2017.27 · Cited by 25
Serological biomarkers for management of primary sclerosing cholangitis
Tornai, D., Ven, P. L., Lakatos, P. L., & Papp, M. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i21.2291 · Cited by 24
Trivedi, P. J., Arndtz, K., Abbas, N., Telford, A., Young, L. A. J., Banerjee, R., Eddowes, P. J., Jhaveri, K. S., & Hirschfield, G. M. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17944 · Cited by 24
Evolving role of magnetic resonance techniques in primary sclerosing cholangitis
Selvaraj, E. A., Culver, E. L., Bungay, H. K., Bailey, A. A., Chapman, R. W., & Pavlides, M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i6.644 · Cited by 24
Vesterhus, M. N., Nielsen, M. J., Hov, J. R., Saffioti, F., Manon‐Jensen, T., Leeming, D. J., Moum, B. A., Boberg, K. M., Pinzani, M., Karlsen, T. H., et al. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100178 · Cited by 23
Self-citationSaffioti, F., & Mavroeidis, V. K. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i10.1336 · Cited by 24
Self-citationBossen, L., Vesterhus, M. N., Hov, J. R., Färkkilä, M. A., Rosenberg, W. M., Møller, H. J., Boberg, K. M., Karlsen, T. H., & Grønbæk, H. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000315 · Cited by 22
Self-citationFiorucci, S., Urbani, G., Giorgio, C. D., Biagioli, M., & Distrutti, E. (2024) · Cells · doi:10.3390/cells13191650 · Cited by 22
Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases
Corpechot, C. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.08.013 · Cited by 19
Nielsen, M. J., Dolman, G. E., Harris, R., Frederiksen, P., Chalmers, J., Grove, J. I., Irving, W. L., Karsdal, M. A., Patel, K., Leeming, D. J., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100743 · Cited by 20
Mjelle, A. B., Mulabecirovic, A., Hausken, T., Havre, R. F., Gilja, O. H., & Vesterhus, M. N. (2016) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2016.04.016 · Cited by 18
Self-citationCurrent Therapeutics in Primary Sclerosing Cholangitis
Tan, N., Lubel, J. S., Kemp, W. W., Roberts, S. K., & Majeed, A. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00068s · Cited by 19
Saffioti, F., Roccarina, D., Vesterhus, M. N., Hov, J. R., Rosenberg, W. M., Pinzani, M., Pereira, S. P., Boberg, K. M., & Thorburn, D. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13088 · Cited by 16
Self-citationPrimary sclerosing cholangitis
von Seth, E., Karlsen, T. H., Tanaka, A., Ponsioen, C. Y., & Bergquist, A. M. (2026) · The Lancet · doi:10.1016/s0140-6736(25)02582-6 · Cited by 17
Self-citationSchmeltzer, P. A., & Russo, M. W. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194476 · Cited by 15
Laursen, T. L., Bossen, L., Pihl, R., Troldborg, A., Sandahl, T. D., Hansen, A. G., Folseraas, T., Vesterhus, M. N., Grønbæk, H., & Thiel, S. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00515 · Cited by 15
Self-citationGreenman, R., Snir, T., Katav, A., Aricha, R., Mishalian, I., Hay, O., Frankel, M. B., Lawler, J., Saffioti, F., Pinzani, M., et al. (2024) · Cells · doi:10.3390/cells13030209 · Cited by 15
Self-citationTrivedi, P. J. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.013 · Cited by 14
Medical treatment of primary sclerosing cholangitis: What have we learned and where are we going?
Karlsen, T. H., Jørgensen, K. K., & Bergquist, A. M. (2024) · Hepatology · doi:10.1097/hep.0000000000001172 · Cited by 15
Self-citationEndpoints in the design of clinical trials for primary sclerosing cholangitis
Ponsioen, C. Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.015 · Cited by 14
Self-citationSaffioti, F., Hall, A. R., de Krijger, M., Verheij, J., Hübscher, S. G., Maurice, J. B., Luong, T. V., Pinzani, M., Ponsioen, C. Y., & Thorburn, D. (2021) · Liver International · doi:10.1111/liv.14979 · Cited by 14
Self-citationDhillon, A. K., Rupp, C., Bergquist, A. M., Voitl, R., Folseraas, T., Trøseid, M., Midttun, Ø., Ueland, P. M., Karlsen, T. H., Vesterhus, M. N., et al. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2021.1880627 · Cited by 13
Self-citationCholangiocarcinoma: The era of liquid biopsy
Kotsifa, E., Saffioti, F., & Mavroeidis, V. K. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i11.104170 · Cited by 12
Self-citationHirschfield, G. M., Kowdley, K. V., Trivedi, P. J., Eksteen, B., Hameed, B., Vincent, C., Chen, T., Goel, A., Reddy, K. G., Orman, E. S., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.09.016 · Cited by 17
Self-citationThe Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)
Cornillet, M., Villard, C., Rorsman, F., Molinaro, A., Nilsson, E., Kechagias, S., von Seth, E., & Bergquist, A. M. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102526 · Cited by 12
Liver Elastography in Primary Sclerosing Cholangitis Patients Using Three Different Scanner Systems
Mjelle, A. B., Fossdal, G., Gilja, O. H., & Vesterhus, M. N. (2020) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2020.03.025 · Cited by 12
Self-citationNon-invasive diagnosis and follow-up of primary sclerosing cholangitis
Chazouillères, O., Potier, P., Bouzbib, C., Hanslik, B., Heurgué, A., Nguyen-Khac, É., Gournay, J., Tanné, F., Bureau, C., Bourlière, M., et al. (2021) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2021.101775 · Cited by 12
Patel, P. J., Connoley, D. J., Rhodes, F., Srivastava, A., & Rosenberg, W. M. (2019) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563219879962 · Cited by 12
Self-citationSnir, T., Greenman, R., Aricha, R., Frankel, M. B., Lawler, J., Saffioti, F., Pinzani, M., Thorburn, D., Mor, A., & Vaknin, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116042 · Cited by 11
Self-citationWang, J., Huang, R., Liu, J., Lai, R., Liu, Y., Zhu, C., Qiu, Y., He, Z., Yin, S., Chen, Y., et al. (2023) · Journal of Viral Hepatitis · doi:10.1111/jvh.13808 · Cited by 11
UEG Week 2019 Poster Presentations
Jaeger, M.-C., Guiraud, L., Rolland, C., Rolland, C., Belot, A., Sebbag, M., Bermúdez‐Humarán, L. G., Langella, P., Vergnolle, N., & Deraison, C. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619854671 · Cited by 11
Song, C., Lewis, S. C., Kamath, A., Hectors, S. J. C. G., Putra, J., Kihira, S., Bane, O., Ahmad, J., Babb, J. S., Thung, S. N., et al. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02366-9 · Cited by 10
Prognostic models and autoimmune liver diseases
D’Amato, D., & Carbone, M. (2023) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2023.101878 · Cited by 10
Controversies in the management of primary sclerosing cholangitis
Nayagam, J. S. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i5.265 · Cited by 9
Dellavance, A., Fernandes, F. F., Shimabokuro, N., Latini, F. R. M., Baldo, D. C., Barreto, J. A., Marvulle, V., Andrade, L. E. C., & Ferraz, M. L. G. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.08.006 · Cited by 9
The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic review
Al‐Judaibi, B., Segal, D., Marotta, P., Mosli, M., Zou, G., & Feagan, B. (2019) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_478_18 · Cited by 8
Nagelkerke, S. C. J., Draijer, L. G., Benninga, M. A., Koot, B. G. P., & Tabbers, M. M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.05.039 · Cited by 8
Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis
Dhillon, A. K., Kremer, A. E., Kummen, M., Boberg, K. M., Elferink, R. P. J. O., Karlsen, T. H., Beuers, U. H., Vesterhus, M. N., & Hov, J. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-44762-7 · Cited by 8
Self-citationRusso, M. W. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i9.1013 · Cited by 7
Nierath, W., Leitner, E., Reimann, S., Schwarz, R., Hinz, B., Bleich, A., Vollmar, B., & Zechner, D. (2024) · The FASEB Journal · doi:10.1096/fj.202400733r · Cited by 6
(2022) · British Journal of Gastroenterology · doi:10.31488/bjg.1000128 · Cited by 6
Deneau, M. R., Valentino, P. L., Mack, C. L., Alqoaer, K., Amin, M. D., Amir, A. Z., Aumar, M., Auth, M. K. H., Broderick, A., DiGuglielmo, M., et al. (2019) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002522 · Cited by 5
Bowlus, C. L., Thorburn, D., Barclay, S. T., Joshi, D., Londoño, M., Mantry, P., Safadi, R., Aricha, R., Cirillo, C., Frankel, M. B., et al. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003853 · Cited by 4
Self-citation
Metadata
- Authors
- Vesterhus, M., Hov, J. R., Holm, A., Schrumpf, E., Nygård, S., Godang, K., Andersen, I. M., Næss, S., Thorburn, D., Saffioti, F., Vatn, M., Gilja, O. H., Lund‐Johansen, F., Syversveen, T., Brabrand, K., Parés, A., Ponsioen, C. Y., Pinzani, M., Färkkilä, M., Moum, B., Ueland, T., Røsjø, H., Rosenberg, W., Boberg, K. M., & Karlsen, T. H.
- Affiliations
- Oslo University Hospital (NO)
- Royal Free London NHS Foundation Trust (GB)
- Corresponding author
- Karlsen, Tom H.
- ORCID
- Vesterhus, Mette
- Hov, Johannes Roksund
- Nygård, Ståle
- Godang, Kristin
- Andersen, Ina Marie
- Thorburn, Douglas
- Saffioti, Francesca
- Gilja, Odd Helge
- Lund‐Johansen, Fridtjof
- Syversveen, Trygve
- Parés, Albert
- Ponsioen, Cyriel Y.
- Pinzani, Massimo
- Färkkilä, Martti
- Moum, Bjørn
- Ueland, Thor
- Røsjø, Helge
- Rosenberg, William
- Boberg, Kirsten Muri
- Karlsen, Tom H.
- Venue
- Hepatology
- Published
- 2015-04-28
- Volume
- 62
- Issue
- 1
- Pages
- 188-197
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W1869119189
- Cited by
- 138
- References
- 41
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 11 · 2023: 12 · 2022: 10 · 2021: 13 · 2020: 12 · 2019: 16 · 2018: 16 · 2017: 16 · 2016: 10 · 2015: 5
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0512-10124)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary sclerosing cholangitis, enhanced liver fibrosis test, transplant-free survival, prognostic factors, liver fibrosis, hyaluronic acid, TIMP-1, Mayo risk score, ultrasound elastography, disease activity, ulcerative colitis, liver transplantation, serum biomarkers
- MeSH terms
- Adult, Female, Fibrosis, Humans, Liver, Male, Middle Aged, Norway, Severity of Illness Index, Cholangitis, Sclerosing, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
